End-to-End Solutions Planned to Support Key Customer Applications With Increased Cost Flexibility on Long-Read Sequencing Systems MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the commencement of a program intended to expand Multiplexed Arrays Sequencing (MAS-Seq) for new assays on the Sequel II/IIe and Revio™ sequencing systems. This program [...]

BILLERICA, Mass. -- SeqLL Inc. (“SeqLL”, NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today announced the establishment of a two-year Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Justice’s Federal Bureau of Investigation (FBI). Under this CRADA, SeqLL and the FBI Laboratory Division (FBI LD) will seek [...]

Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 million [...]

Comprehensive system that enables unmatched single cell multiomic analysis is now widely available following the completion of a successful Early Access Program DURHAM, N.C. –- BioSkryb Genomics, a pioneer in comprehensive single cell multiomic research solutions, today announced the commercial launch of its ResolveOME™ Whole Genome and Transcriptome Amplification system and BaseJumper™ Bioinformatics Platform at the Advances in Genome [...]

Eclipsebio’s eSHAPE™ product family is a combination of kits, services, and databases, that facilitates the study of RNA secondary structure in both in vitro and in cellulo conditions SAN DIEGO -- Eclipse Bioinnovations (Eclipsebio), a leading RNA genomics company developing and commercializing novel, data-driven technologies that interrogate RNA, today announced the launch of its eSHAPE™ suite of [...]

New immune profiling and enrichment capabilities expand applications and facilitate scalability HOLLYWOOD, FLA. (AGBT GENERAL MEETING) — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercode™ TCR and Gene Capture. These new solutions expand the Parse Biosciences portfolio to address higher scale and immune profiling applications. [...]

SAN DIEGO & CAMBRIDGE, England -- Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and AltemisLab, leaders of sample management consumables and equipment to optimize inventory management workflows, today announced a collaboration that will streamline sample management automation for customers. The companies will also be showcasing their joint technology approach at the SLAS2023 [...]

Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale CAMBRIDGE, England -- EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 [...]

DNBSEQ-T20x2*produces up to 50,000 WGS per year at a first sub hundred-dollar price per genome DNBSEQ-T7* offers an outstanding $1.5/Gb price for sequencing consumables DNBSEQ-G99* delivers a first-in-class PE150 run within 12 hours with a data output of 8- 48 Gb per run stLFR library prep kit enables more complete and accurate haplotype-phased genom HOLLYWOOD, [...]

Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched its new adenovirus quantification application on Stunner today. Stunner can already measure titer and empty/full ratio for AAVs, and now it can do the same for adenoviruses.  Adenoviruses are excellent at transferring [...]